Impact of traditional ayurvedic drug Lipidom and Yogic Intervention vs Conventional Drug on Dyslipidemia.
Not Applicable
Completed
- Conditions
- Health Condition 1: E785- Hyperlipidemia, unspecified
- Registration Number
- CTRI/2022/06/043085
- Lead Sponsor
- Patanjali Research Institute governed by Patanjali Research Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Adult male and non-pregnant female population pre-diagnosed with dyslipidemia.
2. Subject should have TC, TG, LDL, HDL lab parameter range according to NCEP ATP III guideline.
3. BMI 18.5-35 kg/m2
4. Subject willingness to participate and sign the informed consent form and ready to comply with protocol measures.
Exclusion Criteria
1. Uncontrolled diabetes mellitus
2. Medical history of unstable angina.
3. Myocardial infarction.
4. I patients is having active cardiac, hepatic, renal disease or have history of stroke within past three months. If patients having active malignant condition.
5. Pregnant/Lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in laboratory parameters of lipid profile compared to baseline after 3 months of Ayurvedic drug lipidom intervention. <br/ ><br>Change in laboratory parameter of lipid profile compared to baseline after 3 months of yogic practices. <br/ ><br>Change in laboratory parameter of lipid profile compared to baseline after 3 months of conventional treatment.Timepoint: Day 0, week 12
- Secondary Outcome Measures
Name Time Method Changes in quality of life, stress levels, lifestyle modification, and fatigue in patients with dyslipidemia. <br/ ><br>Treatment satisfaction and adherence for specific drug.Timepoint: Day 0, week 6, week 12